Maremmani, Icro

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 141

Methadone Dose and Retention During Treatment of Heroin Addicts with Axis I Psychiatric Comorbidity

Maremmani, I., Zolesi, O., Aglietti, M., Marini, G., Tagliamonte, A., Shinderman, M., & Maxwell, S. (2000) · Journal of Addictive Diseases

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 74

Gamma hydroxybutyric acid (ghb) for the treatment of alcohol dependence: A review

Caputo, F., Vignoli, T., Maremmani, I., Bernardi, M., & Zoli, G. (2009) · International Journal of Environmental Research and Public Health

Substance Abuse Treatment and OutcomesAlcoholism and Thiamine Deficiency

Cited by 73

Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders

Deltito, J. A., Moline, M., Pollak, C., Martin, L. Y., & Maremmani, I. (1991) · Journal of Affective Disorders

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 72

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician

Barbuti, M., Maiello, M., Spera, V., Pallucchini, A., Brancati, G., Maremmani, A., Perugi, G., & Maremmani, I. (2023) · Journal of Clinical Medicine

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 47

The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance

Maremmani, A. G. I., Rovai, L., Bacciardi, S., Rugani, F., Pacini, M., Paolo Pani, P., Osso, L. D., Akiskal, H., & Maremmani, I. (2013) · Journal of Affective Disorders

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 35

Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study

Guiraud, J., Addolorato, G., Aubin, H.-J., Batel, P., de Bejczy, A., Caputo, F., Goudriaan, A. E., Gual, A., Lesch, O., Maremmani, I., et al. (2021) · European Neuropsychopharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 20